These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16269190)

  • 21. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
    Gannon RL; Millan MJ
    Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand dependency of 5-hydroxytryptamine 2C receptor internalization.
    Schlag BD; Lou Z; Fennell M; Dunlop J
    J Pharmacol Exp Ther; 2004 Sep; 310(3):865-70. PubMed ID: 15113845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the neuroendocrine role of serotonin.
    Jørgensen HS
    Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of pyridazinone-based 5-HT(2C) agonists.
    Allerton CM; Andrews MD; Blagg J; Ellis D; Evrard E; Green MP; Liu KK; McMurray G; Ralph M; Sanderson V; Ward R; Watson L
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5791-5. PubMed ID: 19716297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists.
    Shimada I; Maeno K; Kazuta K; Kubota H; Kimizuka T; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2008 Feb; 16(4):1966-82. PubMed ID: 18035544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing the effects of 5-HT(2C) receptor ligands on motor activity and feeding behaviour in 5-HT(2C) receptor knockout mice.
    Fletcher PJ; Tampakeras M; Sinyard J; Slassi A; Isaac M; Higgins GA
    Neuropharmacology; 2009 Sep; 57(3):259-67. PubMed ID: 19501602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of spinal 5-HT2 receptor subtypes in quipazine-induced hindlimb movements after a low-thoracic spinal cord transection.
    Ung RV; Landry ES; Rouleau P; Lapointe NP; Rouillard C; Guertin PA
    Eur J Neurosci; 2008 Dec; 28(11):2231-42. PubMed ID: 19019202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists.
    Heinrich T; Böttcher H; Prücher H; Gottschlich R; Ackermann KA; van Amsterdam C
    ChemMedChem; 2006 Feb; 1(2):245-55. PubMed ID: 16892357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel 2-N,N-dimethylaminomethyl-2,3,3a,12b-tetrahydrodibenzo[b,f]furo[2,3-d]oxepin derivatives displaying combined norepinephrine reuptake inhibition and 5-HT2A/2C receptor antagonism.
    Bartolomé JM; Alcudia A; Andrés JI; Cid JM; García M; Megens A; Toledo MA; Trabanco AA
    Bioorg Med Chem Lett; 2005 Jun; 15(11):2898-901. PubMed ID: 15911276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-HT2C antagonists based on fused heterotricyclic templates: design, synthesis and biological evaluation.
    Hamprecht D; Micheli F; Tedesco G; Donati D; Petrone M; Terreni S; Wood M
    Bioorg Med Chem Lett; 2007 Jan; 17(2):424-7. PubMed ID: 17079142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery.
    Bond RA; Ijzerman AP
    Trends Pharmacol Sci; 2006 Feb; 27(2):92-6. PubMed ID: 16406086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased hypothalamic 5-HT2A receptor gene expression and effects of pharmacologic 5-HT2A receptor inactivation in obese Ay mice.
    Nonogaki K; Nozue K; Oka Y
    Biochem Biophys Res Commun; 2006 Dec; 351(4):1078-82. PubMed ID: 17097612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of 5-HT2C receptors acutely induces Per1 gene expression in the rat SCN in vitro.
    Varcoe TJ; Kennaway DJ
    Brain Res; 2008 May; 1209():19-28. PubMed ID: 18400210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological evidence for a functional serotonin-2B receptor in a human uterine smooth muscle cell line.
    Kelly CR; Sharif NA
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1254-61. PubMed ID: 16517693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutive activity of the histamine H3 receptor.
    Arrang JM; Morisset S; Gbahou F
    Trends Pharmacol Sci; 2007 Jul; 28(7):350-7. PubMed ID: 17573125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
    Shireman BT; Dvorak CA; Rudolph DA; Bonaventure P; Nepomuceno D; Dvorak L; Miller KL; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2103-8. PubMed ID: 18282705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic neurotransmission in the dorsal raphe nucleus recruits in situ 5-HT(2A/2C) receptors to modulate the post-ictal antinociception.
    Freitas RL; Bassi GS; de Oliveira AM; Coimbra NC
    Exp Neurol; 2008 Oct; 213(2):410-8. PubMed ID: 18671968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse agonism: more than reverting constitutively active receptor signaling.
    Dupré DJ; Rola-Pleszczynski M; Stanková J
    Biochem Cell Biol; 2004 Dec; 82(6):676-80. PubMed ID: 15674435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.